Synthesis, molecular modelling, and biological evaluation of novel quinoxaline derivatives for treating type II diabetes

Quinoxalines are benzopyrazine derivatives with significant therapeutic impact in the pharmaceutical industry. They proved to be useful against inflammation, bacterial, fungal, viral infection, diabetes and other applications. Very recently, in January 2024, the FDA approved new quinoxaline containi...

Full description

Bibliographic Details
Published in:Journal of Enzyme Inhibition and Medicinal Chemistry
Main Author: Alasmary F.A.S.; Abdullah D.A.; Masand V.H.; Ben Bacha A.; Omar Ebeid A.M.; El-Araby M.E.; Alafeefy A.M.
Format: Article
Language:English
Published: Taylor and Francis Ltd. 2024
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85204755142&doi=10.1080%2f14756366.2024.2395985&partnerID=40&md5=fe821bf9fa1fe8b3edbe39a5d37af6ce

Similar Items